cbdMD (YCBD) Stock Price
cbdMD Price
Over the last 10 years cbdMD grew revenue by 108.2% annually, reaching 19.19 M USD. For cbdMD, the net margin of -10.6% is up versus -52.6% a few years ago.
cbdMD stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
cbdMD business model & stock analysis
Frequently asked questions about cbdMD
6 analysts currently rate the cbdMD stock: 0 recommend buying, 3 holding and 3 selling. For 2026, analysts expect cbdMD to generate revenue of 21.92 M USD and earnings per share of -0.38 USD.
Converted at the current exchange rate, the cbdMD share trades at 0.36 EUR (0.41 USD).
The expected revenue of cbdMD is 21.92 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of cbdMD is -3.47 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of cbdMD is currently -1.06. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the cbdMD stock.
The price-to-sales ratio (P/S) of cbdMD is currently 0.17. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the cbdMD stock.
The Eulerpool Quality Score for cbdMD is 4/10.
The ISIN of cbdMD is US12482W4087. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of cbdMD is A2PJM3. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of cbdMD is YCBD. The ticker symbol is used to trade cbdMD shares on the stock exchange.
cbdMD stock
cbdMD Peer Group
cbdMD Ticker
All fundamentals and in-depth analysis of cbdMD
Our stock analysis for cbdMD stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of cbdMD. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.